Gamma scintigraphy is a powerful and versatile technology, which can be used to investigate the in-vivo performance of your drug or product. This non-invasive imaging technique allows you to follow the fate of your dosage form in-vivo. Scintigraphy can be coupled with PK analysis to give a complete picture of your product’s behaviour. BDD is market leaders in gamma scintigraphy with a proven track record and a global client base. Data obtained on the in-vivo performance of your formulation can help define your formulation development strategy, reducing costs and time to market. Scintigraphic can also be used to support drug delivery claims, for marketing or regulatory purposes. Download to find out more.